Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET

被引:14
作者
Francis, DL
Visvikis, D
Costa, DC
Croasdale, I
Arulampalam, TH
Luthra, SK
Taylor, I
Ell, PJ
机构
[1] UCL, Middlesex Hosp, Inst Nucl Med, London, England
[2] UCL, Middlesex Hosp, Dept Surg, London, England
[3] Hammersmith Hosp, IRSL Cyclotron Unit, London, England
关键词
D O I
10.1007/s00259-003-1438-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[No abstract available]
引用
收藏
页码:928 / 928
页数:1
相关论文
共 2 条
[1]   Potential impact of [18F]3′-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy--glucose in positron emission tomography for colorectal cancer [J].
Francis, DL ;
Visvikis, D ;
Costa, DC ;
Arulampalam, THA ;
Townsend, C ;
Luthra, SK ;
Taylor, I ;
Ell, PJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (07) :988-994
[2]   Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? [J].
Price, P ;
Jones, T .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (12) :1924-1927